Article Text

Download PDFPDF
Summary of report of the 3rd Workshop of European Biologics Registries
  1. A Zink1,
  2. A Silman2,
  3. L Klareskog3
  1. 1Deutsches Rheuma-Forschungszentrum Berlin, Berlin, Germany
  2. 2ARC Epidemiology Research, University of Manchester, UK
  3. 3Karolinska Hospital, Stockholm, Sweden
  1. Correspondence to:
    Dr A Zink
    zinkdrfz.de

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

The national societies of rheumatology in several European countries have initiated independent registries to observe the long term outcomes (safety, effectiveness, and costs) of treatments with biological agents. The …

View Full Text